Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

January 4, 2016January 4, 2016

Malaria Vaccine Can Kill Cancer Cells

News

In a study entitled “Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein” researchers report that, while attempting to find a malaria vaccine that fights the disease in pregnant women, they ... Read more

December 18, 2015December 18, 2015

In Pediatric Hodgkin Lymphoma, Chemotherapy Alone May Suffice as Treatment

News

Novel clinical results suggest systemic chemotherapy alone is an effective therapy in pediatric Hodgkin lymphoma. The study, titled “Clinical Profile and Chemotherapy Response in Children with Hodgkin Lymphoma at a Tertiary ... Read more

December 2, 2015December 2, 2015

Lymphoma Study Traces 2 Key Players’ Opposing Roles in B Cell Development

News

In a new study, scientists discovered that two key players in B cells, PI3 Kinase and FOXO1, have opposing roles in controlling B cell proliferation and differentiation in germinal centers, with implications ... Read more

December 1, 2015December 1, 2015

Combo Therapy May Ease Lymphoma Risk in Young Organ Transplant Patients

News

A combination immunosuppressive therapy of cyclosporin A with everolimus may be an effective treatment for pediatric patients undergoing to organ transplants. These are the results of a study recently published in the journal International ... Read more

November 24, 2015November 24, 2015

Areas in Pediatric Hodgkin Lymphoma Research Still Lacking, Study Finds

News

In a new review entitled “Hodgkin Lymphoma in Children and Adolescents: Improving the Therapeutic Index” a researcher at the Columbia University Medical Center, New York, highlighted the areas in pediatric ... Read more

October 28, 2015October 28, 2015

Lymphoma Patients May Benefit from Discovery of 3,000 New Genes Impacting Immune System

News

Novel findings by UCLA researchers may help immunologists better understand immune cell generation and uncover mechanisms responsible for immune system-related diseases, such as lymphomas. In the study entitled “Long non-coding RNA profiling of human ... Read more

October 26, 2015October 26, 2015

Lymphoma Growth May Be Blocked by Loop That Control’s Enzyme Activity

News

In a new study recently published in the journal Cell and supported by the Leukemia and Lymphoma Society, researchers report a new mechanism regulating gene expression that appears to prevent ... Read more

September 22, 2015September 22, 2015

Combining MRI with Specific Biomarkers Strengths CNS Lymphoma Diagnosis

News

In a recent study entitled “The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma” authors report that ... Read more

August 7, 2015August 7, 2015

Study Finds Molecule Can Differentiate Immune Cells

News

In a new study entitled “C/EBPα Activates Pre-existing and De Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis” scientists discovered that the transcription factor C/EBPα is the only ... Read more

July 27, 2015July 27, 2015

Personalized Treatment for B cell Lymphoma Patients with Specific ABC Subtype

News

In a new study entitled “Targeting B-Cell Receptor Signaling with Ibrutinib in Diffuse Large B-Cell Lymphoma” a team of researchers identified a subtype of diffuse large B cell lymphoma (DLBCL) ... Read more